Skip to main content

Table 1 Demographics and clinical characteristics of groups (n:230)

From: The repeatability of corneal topography measurements in severe Dry Eye disease

 

Dry Eye patients (n:138)

Control subjects (n:92)

p

Sex- female

39 (56.5%)

24 (52.2%)

0.646*

Age, years

40.8 ± 13.2

39.8 ± 8.2

0.604

BCVA, Snellen

0.91 ± 0.1

0.94 ± 0.1

0.071

SE, D

-0.35 ± 0.3

-0.38 ± 0.3

0.433

IOP, mmHg

14.9 ± 3

14.0 ± 2.7

0.295

TBUT, seconds

1.32 ± 0.8

15.2 ± 3.2

< 0.001

Schirmer test, mm/5 min

0.06 ± 0.3

25.7 ± 6.3

< 0.001

Corneal fluorescein staininga

5.89 ± 2.1

0.24 ± 0.4

< 0.001

Conjunctival fluorescein stainingb

1.71 ± 1.1

0.2 ± 0.4

< 0.001

OSDI score

61.62 ± 15

4.21 ± 2.8

< 0.001

  1. Data are presented as mean ± standard deviation or number (%), where appropriate.
  2. BCVA Best corrected visual acuity; SE Spheric equivalent; D Diopter; IOP Intraocular pressure; TBUT Tear break-up time; OSDI Ocular surface disease index.
  3. aNEI/industry-recommended scale (0: no staining, 15: severe staining)
  4. bOxford staining scale 0 to 5 (0: no staining, 5: severe staining)
  5. * Chi-square test
  6. Independent Student’s t test
  7. General Estimating Equations